Cargando…

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease

BACKGROUND: We hypothesized that the total volume of metastases at initial oligometastatic (OM) presentation to stereotactic body radiation therapy (SBRT) is an important prognostic factor that can refine the definition of OM disease. METHODS: Patients with extracranial oligometastatic cancer (≤5 le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yilin, Chen, Hanbo, Sahgal, Arjun, Erler, Darby, Badellino, Serena, Biswas, Tithi, Dagan, Roi, Foote, Matthew C., Louie, Alexander V., Poon, Ian, Ricardi, Umberto, Redmond, Kristin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607244/ https://www.ncbi.nlm.nih.gov/pubmed/34668651 http://dx.doi.org/10.1002/cam4.4332

Ejemplares similares

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
por: Baydoun, A., et al.
Publicado: (2021)

Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials
por: Baydoun, Atallah, et al.
Publicado: (2022)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Volumetric assessment of extracranial carotid artery aneurysms
por: de Vries, E. E., et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Defining Oligometastatic Bladder Cancer: A Systematic Review
por: Bamias, Aristotelis, et al.
Publicado: (2023)

Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation
por: Huo, Michael, et al.
Publicado: (2017)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
por: Udovicich, Cristian, et al.
Publicado: (2022)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial
por: DEODATO, FRANCESCO, et al.
Publicado: (2013)

Volumetric Flow Assessment in Extracranial Arteries in Patients with 70–99% Internal Carotid Artery Stenosis
por: Kaszczewski, Piotr, et al.
Publicado: (2022)

Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis
por: Li, Alyssa Y., et al.
Publicado: (2023)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Long‐term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
por: Wijetunga, N. Ari, et al.
Publicado: (2021)

Radiation therapy for oligometastatic bone disease in breast cancer
por: Katayama, Norihisa, et al.
Publicado: (2020)

Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer
por: Li, Huzi, et al.
Publicado: (2020)

Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions
por: Zayed, Sondos, et al.
Publicado: (2023)

A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors
por: Morgan, Jessica E., et al.
Publicado: (2020)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely
por: Pinkham, Mark B., et al.
Publicado: (2017)

Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
por: Mahjoub, Samy, et al.
Publicado: (2021)

Separation surgery for metastatic epidural spinal cord compression: A qualitative review
por: Di Perna, Giuseppe, et al.
Publicado: (2020)

Charactering tumor microenvironment reveals stromal‐related transcription factors promote tumor carcinogenesis in gastric cancer
por: Liu, Haining, et al.
Publicado: (2020)

Prognostic impacts of extracranial metastasis on non‐small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database
por: Wang, Miao, et al.
Publicado: (2020)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature
por: Khattab, Mohamed H., et al.
Publicado: (2015)

Feasibility and Optimal Time Point of [(68)Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
por: Huebner, Nicolai, et al.
Publicado: (2022)

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
por: Shao, Yilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uivt5n78nulfvhumlmrhpimgs